Holdsworth House Research will change its name to Momentum Clinical Research from 1 July 2024.
Clinical Study

COVID-19 Vaccine Research Study (COVE 401)



Principal Investigator
A/Prof Mark Bloch

The COVE 401 Study will monitor the immune response of adult participants who receive the investigational mRNA COVID-19 vaccine.

Investigational Treatment

The investigational mRNA COVID-19 vaccine may help protect people from getting sick if they come into contact with the COVID-19 virus, including the newer variants, and will be compared to another mRNA COVID-19 vaccine that is approved for use in Australia.

What's Involved

You will be required to come to our clinic up to 3 times over a period of 2 weeks.  At each visit you will see the study doctor and then the research team for vaccination, blood sample collection, and assessments.

There is no cost for the investigational vaccine or study visits, and you will be compensated for time and travel.


You may qualify if you:

  • Are aged 18 or older
  • Have had 2 primary COVID-19 vaccinations and at least one mRNA booster dose
  • Are generally healthy
  • Have NOT received any other vaccines 28 days before or 2weeks after the trial injection
  • Have NOT been infected with Covid-19 in the last 3 months
  • Are based in Sydney

Further eligibility criteria apply.

Register your interest

Please contact Holdsworth House Research to register your interest, or, use the form to request more information.

Follow the link below to register your interest:
Complete form